Three things to know:
1. Mr. Loerop will supervise Anika’s global business development including management of new business opportunities, initiatives, mergers, acquisitions, partnerships and licensing agreements.
2. He has over 30 years of experience in business and corporate development in the biopharma sector.
3. Mr. Loerop served in leadership roles at Lupin Pharmaceuticals, Alexion Pharmaceuticals, GlaxoSmithKline and Steifel Laboratories.
“Jim’s depth of knowledge and experience will be instrumental to the refinement and execution of our long-term growth strategy, which will include identifying partnership opportunities to expand our commercial portfolio and global footprint,” said Joseph Darling, President and CEO of Anika.
More articles on devices:
Cerapedics expands Colorado HQ — 3 things to know
HSS acquires low-dose orthopedic imaging system — 3 insights
Medtronic secures market-leading position through Titan Spine acquisition, analyst says
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
